Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OPKO HEALTH, INC.

(OPK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 1 7659782 6472 561--
Entreprise Value (EV)1 1 7659782 6472 5612 5612 561
P/E ratio -11,1x-2,77x79,0x-207x-68,9x124x
Yield ------
Capitalization / Revenue 1,78x1,08x1,84x1,62x2,16x2,05x
EV / Revenue 1,78x1,08x1,84x1,62x2,16x2,05x
EV / EBITDA -25,6x-7,42x24,0x39,2x32,6x18,3x
Price to Book 0,95x-----
Nbr of stocks (in thousands) 586 332665 601670 000681 163--
Reference price (USD) 3,011,473,953,723,723,72
Announcement Date 02/27/201902/26/202002/18/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 9909021 4351 5761 1871 246
EBITDA1 -68,9-13211065,378,6140
Operating profit (EBIT)1 -166-27457,713,9-22,934,7
Operating Margin -16,8%-30,4%4,02%0,88%-1,93%2,79%
Pre-Tax Profit (EBT)1 -177-30548,7-3,90-36,921,5
Net income1 -153-31530,6-10,9-38,619,2
Net margin -15,4%-34,9%2,13%-0,69%-3,25%1,54%
EPS2 -0,27-0,530,05-0,02-0,050,03
Dividend per Share ------
Announcement Date 02/27/201902/26/202002/18/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1
Net sales1 495545442302286352
EBITDA1 56,650,118,1-4,601,70-
Operating profit (EBIT)1 49,338,55,60-6,72-23,418,4
Operating Margin 9,97%7,06%1,27%-2,22%-8,17%5,22%
Pre-Tax Profit (EBT)1 45,931,7-11,3-4,04-27,315,0
Net income1 32,331,1-16,2-5,24-27,713,8
Net margin 6,53%5,70%-3,66%-1,73%-9,66%3,92%
EPS2 0,050,05-0,03-0,01-0,040,02
Dividend per Share ------
Announcement Date 02/18/202104/28/202107/29/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt ------
Net Cash position ------
Leverage (Debt / EBITDA) ------
Free Cash Flow1 -137-1855,7954,497,4131
ROE (Net Profit / Equities) -8,42%-----
Shareholders' equity1 1 817-----
ROA (Net Profit / Asset) -6,07%-----
Assets1 2 520-----
Book Value Per Share 3,18-----
Cash Flow per Share ------
Capex1 27,912,733,727,127,027,8
Capex / Sales 2,81%1,41%2,35%1,72%2,28%2,23%
Announcement Date 02/27/201902/26/202002/18/2021---
1 USD in Million
Key data
Capitalization (USD) 2 561 171 447
Net sales (USD) 1 435 400 000
Number of employees 5 269
Sales / Employee (USD) 272 424
Free-Float 59,5%
Free-Float capitalization (USD) 1 524 421 336
Avg. Exchange 20 sessions (USD) 10 147 889
Average Daily Capital Traded 0,40%
EPS & Dividend